Skip to content

Where Biophotonics meets the Future

The International Congress on Biophotonics (ICOB) is a unique and future-oriented conference series dedicated to the advancement and application of light-based technologies in medicine and the life sciences. Since its inception, ICOB has established itself as a central meeting point for a wide range of stakeholders committed to exploring the full potential of biophotonics. The congress goes far beyond the boundaries of a conventional scientific conference — it deliberately opens its doors to industry, clinicians, funding agencies, policymakers, and representatives of society, aiming to foster dialogue across disciplines and sectors.

At the heart of ICOB is the belief that progress in biophotonics requires more than academic excellence. Real-world innovation happens at the interface between research, clinical application, industrial development, and societal needs. ICOB serves as a bridge between these areas by providing a collaborative environment where scientists, engineers, healthcare professionals, and decision-makers can connect, exchange ideas, and jointly define future priorities.

The congress is designed to encourage interdisciplinary cooperation and the development of shared visions — not only to advance the science of biophotonics but also to ensure its successful translation into practice.

One of the defining characteristics of ICOB is its strong emphasis on translation. Recognizing the increasing relevance of biophotonic technologies in diagnostics, therapy, and health monitoring, the congress focuses on how research findings can be turned into tangible solutions. From non-invasive imaging and sensing at the molecular level to the integration of AI in biophotonics and the development of personalized medicine approaches, ICOB highlights innovations that are ready — or close — to entering clinical and commercial use.

In this context, the congress also addresses regulatory challenges, funding opportunities, and the creation of innovation-friendly ecosystems that support the path from discovery to deployment.

ICOB views education, talent development, and strategic planning as essential components of sustainable progress in biophotonics. The congress places a strong emphasis on nurturing the next generation of researchers and innovators by highlighting educational initiatives and providing young professionals with opportunities to engage in meaningful discussions and networking.

Each edition of ICOB contributes to long-term planning in the field. A key outcome of the congress should be a strategy paper that captures the most relevant insights and recommendations from the event. This document serves as a roadmap, offering a strategic perspective for stakeholders across science, industry, policy, and society.

The ICOB congresses feature a rich and varied program, including keynote lectures by leading experts, thematic sessions, panel discussions, and an industry exhibition. This diversity ensures that attendees gain a comprehensive view of current trends and emerging technologies while also having ample opportunities to build connections and initiate collaborations.

By creating space for scientific exchange, political dialogue, and industrial networking, ICOB acts as a catalyst for innovation and strategic partnerships that drive the biophotonics field forward.

ICOB brings together a growing international community that is dedicated to harnessing the power of light for the benefit of human health and well-being. The congress series not only reflects the current state of the field but actively shapes its trajectory by uniting the voices of those who research, fund, regulate, apply, and benefit from biophotonics.

With its inclusive, interdisciplinary, and impact-oriented approach, the International Congress on Biophotonics is a vital platform for collectively envisioning — and realizing — the future of biophotonics.

ICOB is organized by

The Center for Biophotonic Technology and Artificial Intelligence (CeBAI) brings together photonic technologies and artificial intelligence (AI) to develop innovative solutions for medicine and forensics, and to accelerate their path to market.

CeBAI was jointly initiated by the University at Albany and the Leibniz Institute of Photonic Technology in Jena, Germany, in June 2024. The Institute for Molecular Science and Fusion Technology at Kangwon National University in Gangwon, South Korea, joined the venture in October 2024.

The Leibniz Institute of Photonic Technology (Leibniz IPHT) develops light-based solutions that address major societal challenges in health, medicine, the environment, energy, and security—contributing to a safer, healthier, and more sustainable future.

Research at the institute focuses on biophotonic methods and technologies that advance the frontiers of resolution, sensitivity, specificity, speed, accuracy, and automation. This work provides the foundation for faster and more precise medical diagnostics, innovative therapies, and safe pharmaceuticals, as well as for improved standards in food and environmental analysis, sustainable energy applications, and next-generation security technologies.

The University at Albany, SUNY is a leading public research university known for academic excellence, cutting-edge research, and a strong commitment to opportunity and impact. With world-class faculty and a global outlook, it empowers students and researchers to innovate, build meaningful connections, and shape a better future. UAlbany strives to be a national leader in higher education—delivering the talent, knowledge, and solutions society needs.

Biophotonics4Future stands for high-quality scientific events in the field of translation in biophotonics. By bringing national and international experts from different scientific fields together, the Biophotonics4Future events aim to identify so-called „unmet needs“ and develop appropriate solutions. Leibniz IPHT invites you to join our numerous conferences, workshops, and symposia. Get in contact with internationally renowned researchers and participate in advancing the important research and translation issues of the future in the field of biophotonics.

Date

18 – 21 March 2026

Congress Chairs

Igor Lednev

University at Albany, SUNY, United States

Juergen Popp

Leibniz Institute of Photonic Technology, Jena, Germany

Congress Management

Ewelina Mistek-Morabito

University at Albany, SUNY, United States